Artelo Biosciences News

4: Statement of changes in beneficial ownership of securities-Director Blayney Douglas

Dec 23, 2024 16:08 ET

4: Statement of changes in beneficial ownership of securities-Director Reyes Gregory

Dec 23, 2024 16:08 ET

4: Statement of changes in beneficial ownership of securities-Director EMANUELE ROBERT MARTIN

Dec 23, 2024 16:08 ET

4: Statement of changes in beneficial ownership of securities-Director Kelly Steven

Dec 23, 2024 16:08 ET

4: Statement of changes in beneficial ownership of securities-Director MATSUI CONNIE

Dec 23, 2024 16:06 ET

4: Statement of changes in beneficial ownership of securities-Director FAVORITO TAMARA A

Dec 23, 2024 16:01 ET

8-K: Current report

Dec 20, 2024 16:50 ET

10-Q: Q3 2024 Earnings Report

Nov 12, 2024 11:30 ET

ARS: Annual Report to Security Holders

Nov 8, 2024 16:37 ET

DEF 14A: Definitive information statements

Nov 8, 2024 16:36 ET

DEFA14A: Others

Nov 8, 2024 16:35 ET

10-Q: Q2 2024 Earnings Report

Aug 13, 2024 08:12 ET

25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)

Jun 17, 2024 17:30 ET

10-Q: Q1 2024 Earnings Report

May 13, 2024 09:19 ET

Artelo Biosciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 29, 2024 12:46 ET

Artelo Biosciences | 10-K: FY2023 Annual Report

Mar 25, 2024 08:03 ET

Artelo Biosciences | 8-K: Current report

Mar 4, 2024 16:27 ET

Artelo Biosciences | 4: Statement of changes in beneficial ownership of securities-Director FAVORITO TAMARA A

Mar 1, 2024 20:55 ET

Artelo Biosciences | 4: Statement of changes in beneficial ownership of securities-Director EMANUELE ROBERT MARTIN

Mar 1, 2024 20:10 ET

Artelo Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Kelly Steven

Mar 1, 2024 20:10 ET